C.M. Bidwell & Associates’s Idexx Laboratories IDXX Stock Holding History

C.M. Bidwell & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-424	Closed	-$207K	–	598
2021 Q1	$207K	Buy	+424	New	+$212K	0.15%	127
2018 Q3	–	Sell	-1,520	Closed	-$331K	–	418
2018 Q2	$331K	Sell	1,520 -15	-1%	-$3.09K	0.31%	89
2018 Q1	$294K	Sell	1,535 -785	-34%	-$145K	0.27%	102
2017 Q4	$363K	Sell	2,320 -1,055	-31%	-$166K	0.31%	93
2017 Q3	$525K	Sell	3,375 -22,160	-87%	-$3.5M	0.81%	34
2017 Q2	$4.12M	Sell	25,535 -6,155	-19%	-$1,000K	0.88%	55
2017 Q1	$4.9M	Sell	31,690 -10	-0%	-$1.38K	1.1%	24
2016 Q4	$3.72M	Sell	31,700 -5,305	-14%	-$605K	0.88%	57
2016 Q3	$4.17M	Buy	37,005 +185	+0.5%	+$19.5K	0.99%	32
2016 Q2	$3.42M	Sell	36,820 -9,725	-21%	-$835K	0.85%	74
2016 Q1	$3.65M	Buy	46,545 +42,530	+1,059%	+$3.06M	0.91%	59
2015 Q4	$293K	Sell	4,015 -17,775	-82%	-$1.27M	0.07%	133
2015 Q3	$1.62M	Buy	+21,790	New	+$1.56M	0.4%	83

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

C.M. Bidwell & Associates's IDXX Position: Q2 2021 in Review

C.M. Bidwell & Associates sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 424 shares — an estimated $207K sold.

C.M. Bidwell & Associates first reported a position in IDXX in Q3 2015 and held it in 13 quarters. The position peaked at $4.9M in Q1 2017. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

C.M. Bidwell & Associates reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
C.M. Bidwell & Associates sold 424 Idexx Laboratories shares in Q2 2021, an estimated $207K.
C.M. Bidwell & Associates first reported a position in Idexx Laboratories in Q3 2015 and held it in 13 quarters.
C.M. Bidwell & Associates's Idexx Laboratories position peaked at $4.9M in Q1 2017.
1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2021, filed 13 Aug 2021.